Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
AUTHORS
Gradishar
WJ ,
Moran
MS ,
Abraham
J ,
Aft
R ,
Agnese
D ,
Allison
KH ,
Anderson
B ,
Burstein
HJ ,
Chew
H ,
Dang
C ,
Elias
AD ,
Giordano
SH ,
Goetz
MP ,
Goldstein
LJ ,
Hurvitz
SA ,
Isakoff
SJ ,
Jankowitz
RC ,
Javid
SH ,
Krishnamurthy
J ,
Leitch
M ,
Lyons
J ,
Mortimer
J ,
Patel
SA ,
Pierce
LJ ,
Rosenberger
LH ,
Rugo
HS ,
Sitapati
A ,
Smith
KL ,
Smith
ML ,
Soliman
H ,
Stringer-Reasor
EM ,
Telli
ML ,
Ward
JH ,
Wisinski
KB ,
Young
JS ,
Burns
J ,
Kumar
R ,
. Journal of the National Comprehensive Cancer Network : JNCCN. ; 20(6). 691-722
- PMID: 35714673 [PubMed].
ABSTRACT
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.
Tags: alumni publications 2022